Research map: Cardiovascular Toxicity of BTKi in Chronic B-Cell Malignancies

Back to the article

Papers in this map

  1. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation · Stefanie Dimmeler · 1999 · 3608 citations · Cited by this paper
  2. Predictors of Outcomes in Patients With Clinically Suspected Myocarditis: Analysis From a Single Center Registry · 2026 · Related
  3. The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolism · Gerta Hoxhaj · 2019 · 2228 citations · Cited by this paper
  4. Bayes Syndrome and Myocardial Fibrosis: Mechanistic Links and Clinical Implications · 2026 · Related
  5. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation · Craig T. January · 2019 · 2224 citations · Cited by this paper
  6. Exploration of the Pathogenesis and Treatment of Heart Failure · 2026 · Related
  7. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial · John C. Byrd · 2021 · 673 citations · Cited by this paper
  8. Potential Relationship Between Ferroptosis and Pyroptosis in Myocardial Ischemia/Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets · 2026 · Related
  9. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management · Sunitha Shyam Sunder · 2023 · 507 citations · Cited by this paper
  10. Cost Impact of a Coronary Computed Tomography Angiography-Based Diagnostic Pathway for Low-Risk Chest Pain in the Emergency Department · 2026 · Related
  11. Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia · Jennifer R. Brown · 2022 · 492 citations · Cited by this paper
  12. Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease? · 2026 · Related
  13. Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results · Michael Wang · 2015 · 413 citations · Cited by this paper
  14. Poor Distal Left Atrial Appendage Opacification on Early-Phase Cardiac CTA and Association With Arterial Thromboembolism · 2026 · Related
  15. Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials · Jennifer R. Brown · 2017 · 267 citations · Cited by this paper
  16. Pericardial Diseases in Cardiovascular Medicine: Contemporary Diagnosis, Risk Stratification, Multimodality Imaging, and Targeted Anti-Inflammatory Therapy · 2026 · Related
  17. Cardiovascular Toxicities Associated With Ibrutinib · Joe‐Elie Salem · 2019 · 266 citations · Cited by this paper
  18. Prophylactic Methylprednisolone in Neonatal On-Pump Cardiac Surgery · 2026 · Related
  19. Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase · Ling Xiao · 2020 · 246 citations · Cited by this paper
  20. Comparative Efficacy of Integrated Stent-Graft versus Conventional Covered Stent-Graft Alone in Type B Aortic Dissection: A Retrospective Study Focusing on Aortic Remodeling and Branch Perfusion · 2026 · Related
  21. Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis · Daniel Caldeira · 2019 · 159 citations · Cited by this paper
  22. Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial · John Francis Seymour · 2023 · 140 citations · Cited by this paper
  23. Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia · Cooper Quartermaine · 2023 · 128 citations · Cited by this paper
  24. Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases · Claudia Renata Rezende Penna · 2025 · 116 citations · Cited by this paper
  25. Sympathetic overactivity, hypertension and cardiovascular disease: state of the art · Guido M. Grassi · 2024 · 84 citations · Cited by this paper
  26. PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea? · Mohammad Badran · 2022 · 37 citations · Cited by this paper
  27. Untitled · Cited by this paper
  28. Untitled · Cited by this paper
  29. Untitled · Cited by this paper
  30. Untitled · Cited by this paper
  31. Untitled · Cited by this paper
  32. Untitled · Cited by this paper
  33. Untitled · Cited by this paper
  34. Untitled · Cited by this paper
  35. Untitled · Cited by this paper
  36. Untitled · Cited by this paper
  37. Untitled · Cited by this paper
  38. Untitled · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)